Details
Instructions for Use
-
Active Ingredient: Mirabegron 25mg
-
Manufacturer: Astellas Pharma Europe B.V., Netherlands
-
Marketing Authorization Holder: Astellas Pharma Malaysia Sdn Bhd
-
Product Registration Number (MAL): MAL15015106ACRZ
- Content: A prolonged-release film-coated tablet designed for oral administration
-
Indications
Betmiga is indicated for the symptomatic treatment of
-
Urgency (sudden, strong need to urinate)
-
Increased micturition frequency (frequent urination)
-
These symptoms may occur in adult patients with overactive bladder (OAB) syndrome.
-
Urgency incontinence (involuntary leakage of urine)
-
Dosage: The recommended starting dose is 25 mg once daily.
-
Administration: Swallow the tablet whole with water; do not chew, crush, or divide.
-
With or Without Food: May be taken with or without food.
-
Consistency: Take at the same time each day to help remember.
-
Missed Dose: If more than 12 hours have passed since the missed dose, skip it and take the next dose at the usual time.
View more about Betmiga 25mg Tab - 30's on main site